Advanced Drug Delivery Reviews

Scope, open access and whether your paper fits

Advanced Drug Delivery Reviews is a materials science journal published by Elsevier BV since 1978. Below: what it publishes, its open-access status and citation figures from OpenAlex, and a short checklist for deciding whether to submit there.

Review my paper

Publisher
Elsevier BV
Field
Materials Science · Biomaterials
Access
Subscription, with an open-access option listed at about $5,550
h-index
435
2-year mean citedness
16.41
Works indexed
5,435
ISSN-L
0169-409X

What it publishes

The topics Advanced Drug Delivery Reviews publishes most on, according to OpenAlex:

  • Nanoparticle-Based Drug Delivery
  • Advanced Drug Delivery Systems
  • RNA Interference and Gene Delivery
  • Drug Solubulity and Delivery Systems
  • Advancements in Transdermal Drug Delivery
  • Tissue Engineering and Regenerative Medicine
  • Drug Transport and Resistance Mechanisms
  • Nanoplatforms for cancer theranostics

How much it publishes

YearWorks indexed in OpenAlex
2026126
2025147
2024137
2023206
2022276
2021338

The latest year may be incomplete while indexing catches up.

Is your paper a fit?

  • Read the aims and scope on the journal’s own site: OpenAlex topics describe what it has published, not what it wants next.
  • Look at the titles of the last two issues: has it published work like yours recently?
  • Check the article types it accepts, word limits and any reporting checklist it requires.
  • Check the article fee, waivers and your funder’s open-access rules.
  • Compare it with similar journals below, and use the free journal finder to see where papers like yours were published.

About these figures

Data from OpenAlex (CC0), retrieved 2026-10-22. The h-index and 2-year mean citedness are computed by OpenAlex; 2-year mean citedness is similar in spirit to an impact factor but is not the Clarivate Journal Impact Factor. NoveltyAxis is not affiliated with this journal or its publisher.

Questions

Is Advanced Drug Delivery Reviews open access?

Subscription, with an open-access option listed at about $5,550. Fees change, so confirm on the journal’s site.

What is the h-index of Advanced Drug Delivery Reviews?

435, according to OpenAlex: at least that many of its papers have each been cited at least that many times.

Is Advanced Drug Delivery Reviews the right journal for my paper?

Only if your paper fits its scope and recent content. Run a pre-submission review to see whether the draft is ready, and the journal finder to compare where similar papers were published.